We’re here to help European citizens make sense of stem cells. We provide reliable, independent information and road-tested educational resources on stem cells and their impact on society. We're funded by the European Commission. Learn more.
Malin Parmar heads a research group focused on developmental and regenerative neurobiology at Lund University in Sweden. The ultimate goal of her research is to develop cell therapy for Parkinson’s disease.
At this year’s Hydra summer school I spoke to Malin about how she got started in stem cell research, what she’s working on at the moment, and her view of the prospects for treating Parkinson’s disease with stem cells.
I always wanted to contribute to scientific progress in stem cell research. Stem cells are helping us to understand degenerative disease and cancer, and a deep understanding of their basic biology is a pre-requisite for clinical application. My PhD project, at Strasbourg University in France, was about the plasticity (adaptability to change) of brain stem cells in fruit flies. After graduating, I decided to get deeper knowledge, and joined Prof. Uri Frank’s team in 2013, attracted by the model organism used to understand the basic biology of stem cells.